Mapp Biopharmaceutical, Inc.
CAGE Code: 417U0
NCAGE Code: 417U0
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 137551797
Summary
Mapp Biopharmaceutical, Inc. is an Active Commercial Supplier with the Cage Code 417U0 and is tracked by Dun & Bradstreet under DUNS Number 137551797..
Address
4921 Directors Pl
Ste 100
San Diego CA 92121-3823
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Technet Jarecki Engineering Circle Intl Temple Ralph Corona Consulting Btg Technology Systems Quality Technology Services, Inc. P&D Consultants Inc. Nova Commercial Co Inc Precision Metal Products Co Frut Stix Co Div Of Lafayette Foods Lynx Systems Kjos Neil A Music Co Circle M Construction Lopez Dunn Ramirez And Associates Morton Equipment And Supply Company G G B Drywall Co Ocean Sensors Inc King Communications Compucom Systems Inc
Frequently Asked Questions (FAQ) for CAGE 417U0
- What is CAGE Code 417U0?
- 417U0 is the unique identifier used by NATO Organizations to reference the physical entity known as Mapp Biopharmaceutical, Inc. located at 4921 Directors Pl, Ste 100, San Diego CA 92121-3823, United States.
- Who is CAGE Code 417U0?
- 417U0 refers to Mapp Biopharmaceutical, Inc. located at 4921 Directors Pl, Ste 100, San Diego CA 92121-3823, United States.
- Where is CAGE Code 417U0 Located?
- CAGE Code 417U0 is located in San Diego, CA, USA.
Contracting History for CAGE 417U0 Most Recent 25 Records
- 75A50122C00061
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- 27 Sep 2022
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $109,773,122.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00061
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- 12 Oct 2022
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $109,773,122.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00061
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- 14 Dec 2023
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $134,839,788.58
- Department Of Health And Human Services (Hhs)
- 75A50122C00061
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- 19 Feb 2023
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $126,278,351.58
- Department Of Health And Human Services (Hhs)
- 75A50122C00061
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- 22 Sep 2023
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $134,839,788.58
- Department Of Health And Human Services (Hhs)
- 75A50122C00061
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- 7 Mar 2023
- Procurement Of Therapeutics For Ebola, Sudan And Marburg Viruses
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $126,278,351.58
- Department Of Health And Human Services (Hhs)
- 75A50122C00076
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- 10 Feb 2023
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $78,480,810.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00076
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- 7 Aug 2023
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $110,877,385.03
- Department Of Health And Human Services (Hhs)
- 75A50122C00076
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- 28 Sep 2022
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $78,480,810.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00076
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- 19 Apr 2023
- This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp Or Contractor) Is For The Development Of Mapp?S Therapeutic Intervention Mbp091, As An Immunotherapy For The Treatment Of Marburg Virus Infection.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $98,313,927.26
- Department Of Health And Human Services (Hhs)
- W81XWH21C0121
- Base Year For Macv Contract
- 27 Dec 2021
- Base Year For Macv Contract
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $402,916.69
- Department Of Defense (Dod)
- W81XWH21C0121
- Laboratory Testing. Section 711 (Ndaa) 2019 The (Usamraa), U.S. Army Medical Research And Development Command (Usamrdc) Transferred To The Defense Health Agency (Dha) From The U.S. Army Effective 01 October 2022
- 1 Mar 2023
- Laboratory Testing. Section 711 (Ndaa) 2019 The (Usamraa), U.S. Army Medical Research And Development Command (Usamrdc) Transferred To The Defense Health Agency (Dha) From The U.S. Army Effective 01 October 2022
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $700,416.72
- Department Of Defense (Dod)
- W81XWH21C0121
- Base Year For Macv Contract 5 Month No Cost Extension
- 25 May 2022
- Base Year For Macv Contract 5 Month No Cost Extension
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $402,916.69
- Department Of Defense (Dod)
- W81XWH21C0121
- Base Year For Macv Contract Generates Macv Igg2
- 24 Sep 2021
- Base Year For Macv Contract Generates Macv Igg2
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $314,114.99
- Department Of Defense (Dod)
- W81XWH21C0121
- Base Year For Macv Contract
- 7 Jan 2022
- Base Year For Macv Contract
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $402,916.69
- Department Of Defense (Dod)
- W911QY20C0099
- Sttr Phase Ii
- 17 Mar 2022
- Sttr Phase Ii
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $1,499,004.12
- Department Of Defense (Dod)
- W911QY20C0099
- Base Year
- 20 Apr 2021
- Base Year
- Dcma San Diego
- Department Of Defense (Dod)
- $999,034.12
- Department Of Defense (Dod)
- W911QY20C0099
- Sttr Phase Ii
- 20 Jan 2022
- Sttr Phase Ii
- W6qk Acc-Apg
- Department Of Defense (Dod)
- $1,499,004.12
- Department Of Defense (Dod)
- W911QY20C0099
- Transfer Contract Administration From Army Contracting Command-Aberdeen Proving Ground, Natick Division (Acc-Apg, Natick), Dodaac W911qy To Acc-Apg Edgewood(Acc-Apg, Edgewood), Dodaac W911sr.
- 22 Jun 2023
- Transfer Contract Administration From Army Contracting Command-Aberdeen Proving Ground, Natick Division (Acc-Apg, Natick), Dodaac W911qy To Acc-Apg Edgewood(Acc-Apg, Edgewood), Dodaac W911sr.
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $1,499,004.12
- Department Of Defense (Dod)
- W911QY20C0099
- Sttr Phase Ii
- 28 Apr 2021
- Sttr Phase Ii
- W6qk Acc-Apg Natick
- Department Of Defense (Dod)
- $999,034.12
- Department Of Defense (Dod)
- 75A50120C00198
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- 2 Jun 2022
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $9,636,456.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00198
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- 9 Sep 2021
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $4,931,893.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00198
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- 30 Jan 2023
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $14,087,201.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00198
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- 2 Nov 2021
- Development Of A Pan-Botulinum Neurotoxin Medical Countermeasure
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $4,931,893.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00198
- The Purpose Of This Modification Is To Exercise And Fully Fund Option 4/Clin0005, No-Cost Extension Of Clin0001 Through 6/30/2024, And Revise Travel Costs
- 29 Jun 2023
- The Purpose Of This Modification Is To Exercise And Fully Fund Option 4/Clin0005, No-Cost Extension Of Clin0001 Through 6/30/2024, And Revise Travel Costs
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $16,303,707.00
- Department Of Health And Human Services (Hhs)